Insurance Cycle

Asset management: a new frontier in underwriting RoE?

With risk free rates at decade long highs, investment contribution is now a critical component of returns on equity

Capital markets slowly falling back in love with (re)insurance

ICMR analysis shows (re)insurer P/b’s close to long term highs, but still relatively undervalued

Lloyd’s result not quite as good as predicted - here’s why

Lloyd’s stated year-on-year rate improvement not reflected in reported loss ratios

RISX equity index surge over the last quarter benefits proven leaders

Successful leaders and smart follow-onlys likely to benefit at the expense of a middle market squeeze

Hedging tail risks through capital markets

Enhance solvency using swaps to take advantage immediately post-event

Insurance cycle has opened a window of opportunity for investments in Lloyd’s

To assess whether investments in Lloyd’s are worthwhile, investors’ expected returns must be compared against the weighted average cost of capital (WACC).

When Private Equity met Lloyd’s

It’s all about enhancing performance and timing the exit

The tide may have turned at Lloyd’s, but headwinds remain strong

First look at Lloyd’s 2021 results

Positive earnings for 2021 priced-in despite major cat losses thus far

What do capital markets tell us about premium rate change for the global specialty (re)insurance industry?

The reserving cycle and how to avoid it

The Casualty Actuarial Society publishes reserving paper using probabilistic programming

A new metric to assess the insurance cycle?

Research by ICMR shows that comparing stock performance of specialty re/insurance companies with the S&P 500 can provide new insight into the state of the insurance cycle

Follow the money: Lloyd's cumulative P&L over the last 20 years

Lloyd's wrote £448bn of gross premiums since 2000, incurring gross claims to policyholders of £288bn, delivering a net combined ratio of 98% and generating £20bn for its investors. What happened?